Single platform femtosecond laser announced at ESCRS

Article

Bausch + Lomb and Technolas Perfect Vision have announced the release of the VICTUS femtosecond laser platform at this year's ESCRS meeting in Vienna, Austria.

Bausch + Lomb (B+L) and Technolas Perfect Vision (TPV) have announced the release of the VICTUS femtosecond laser platform that supports cataract, refractive and therapeutic procedures at this year’s ESCRS meeting in Vienna, Austria.

CEO and president of the Global Surgical Business for B+L, Robert E. Grant, commented on the news, stating, "Our focus is on bringing innovative products, like the VICTUS platform, to the market that uniquely benefit ophthalmic surgeons and patients. TPV's advanced German engineering and precise manufacturing are perfect complements to B+L's surgical portfolio."

The companies have announced that early clinical data on the platform will be presented at the upcoming AAO meeting in Orlando, Florida, USA and at the Asia-Pacific Association of Cataract and Refractive Surgeons in Seoul, South Korea. Additionally, both companies are currently working with regulatory authorities to secure marketing approvals and will promote the platform globally.

This news comes shortly after the recent announcement that B+L and TPV entered into a definitive agreement with an option for B+L to purchase all outstanding and not owned TPV shares.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.